首页> 美国卫生研究院文献>Journal of Bacteriology >Valinomycin-induced cation transport in vesicles does not reflect the activity of K+ transport systems in Escherichia coli.
【2h】

Valinomycin-induced cation transport in vesicles does not reflect the activity of K+ transport systems in Escherichia coli.

机译:缬霉素诱导的囊泡中的阳离子转运不能反映大肠杆菌中K +转运系统的活性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Transport systems for K+ in Escherichia coli are not detectable in membrane vesicles, but vesicles will take up K+ (and Rb+) in the presence of valinomycin. It is generally believed that valinomycin acts as a lipid-soluble cation carrier and that it does not interact with or activate cation transport systems. This view is challenged by Bhattacharyya et al. (Proc. Natl. Acad. Sci. USA 68:1448-1492, 1971), who reported reduced uptake in vesicles from E. coli mutants with K+ transport defects. We reexamined this question with some of the same mutants and were unable to confirm a correlation of valinomycin-induced vesicle transport with transport properties in intact cells. We found great variability in transport activity of vesicles from these E. coli K-12 strains and believe such variability as well as possible contamination with intact cells accounts for the earlier report. Our data do not support the idea that valinomycin-mediated transport in vesicles is related to physiological K+ transport systems.
机译:在膜小泡中未检测到大肠埃希氏菌中K +的转运系统,但在存在缬霉素的情况下,小泡将吸收K +(和Rb +)。通常认为缬氨霉素起脂溶性阳离子载体的作用,并且不与阳离子转运系统相互作用或活化阳离子转运系统。这种观点受到了Bhattacharyya等人的质疑。 (Proc.Natl.Acad.Sci.USA 68:1448-1492,1971),他报道了具有K +转运缺陷的大肠杆菌突变体的囊泡摄取减少。我们用一些相同的突变体重新检查了这个问题,并且无法证实缬氨霉素诱导的囊泡转运与完整细胞中转运特性的相关性。我们发现这些大肠杆菌K-12菌株的囊泡转运活性存在很大的差异,并且认为这种差异以及完整细胞的可能污染是早期报道的原因。我们的数据不支持这种想法,认为缬氨霉素介导的囊泡转运与生理性K +转运系统有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号